| Alexandre Lockfeld, MD | |
|
3355 Riverbend Dr, Suite 410, Springfield, OR 97477-8800 | |
| (541) 868-9430 | |
| (541) 868-9450 |
| Full Name | Alexandre Lockfeld |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 3355 Riverbend Dr, Springfield, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275604753 | NPI | - | NPPES |
| 009725 | Medicaid | OR | |
| 130005754 | Other | OR | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD16743 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alexandre Lockfeld, MD 3355 Riverbend Dr, Suite 410, Springfield, OR 97477-8800 Ph: (541) 868-9430 | Alexandre Lockfeld, MD 3355 Riverbend Dr, Suite 410, Springfield, OR 97477-8800 Ph: (541) 868-9430 |
News Archive
A team of researchers from the CHUM Research Centre has identified new biomarkers associated with the severity of COVID-19 in infected patients.
Human behaviors such as violence depend on interactions in the brain between genetic and environmental factors. An individual may be more vulnerable to developing violent behaviors if they have predisposing factors and are then exposed to stress, abuse, or other triggers, especially early in life.
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
A team of Cedars-Sinai Heart Institute stem cell researchers today was awarded a $1.3 million grant from the California Institute of Regenerative Medicine to continue study of an experimental stem cell therapy that treats heart attack patients with heart-derived cells. Earlier this year, data from the first clinical trial of the stem cell treatment showed the therapy helped damaged hearts regrow healthy muscle.
› Verified 9 days ago
Jeffrey R Frank, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Hayden Bridge Way, Springfield, OR 97477 Phone: 541-868-9430 Fax: 541-868-9450 | |
Elizabeth Megan Callan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-8400 Fax: 541-222-8401 | |
James David Sanchez, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 555 International Way, Springfield, OR 97477 Phone: 541-799-3386 | |
Michael R Balm, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Hayden Bridge Way Ste 410, Springfield, OR 97477 Phone: 541-868-9430 Fax: 541-868-9450 | |
Dr. Roberto Antonio Cruz Barahona, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3333 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-2185 Fax: 541-222-2194 | |
Mersedeh Bahr Hosseini, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3311 Riverbend Dr., Neurohospitalists, Springfield, OR 97477 Phone: 541-222-5144 Fax: 541-338-1070 | |
Dr. Kathleen E Wilken, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-6330 |